XOMA Royalty (XOMA) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.59 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -7.69%. A quarter ago, it was expected that this drug developer would post a loss of $0.71 per share when it actually produced a loss of $0.86, delivering a surprise of -21.13%. Over the last four quarters, the company has n ...